These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 6085662)

  • 1. Treatment results of stage III germinal testicular tumors.
    Akdaş A; Kirkali Z; Altuğ U; Ilker Y
    Turk J Pediatr; 1984; 26(1-4):301-6. PubMed ID: 6085662
    [No Abstract]   [Full Text] [Related]  

  • 2. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with PVB in non seminomatous germ-cell cancer of the testis.
    Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M
    Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336
    [No Abstract]   [Full Text] [Related]  

  • 4. Bleomycin in germ cell testicular tumors (GCTT).
    Germa Lluch JR
    Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
    [No Abstract]   [Full Text] [Related]  

  • 5. Vinblastine, cisplatin and bleomycin treatment of advanced nonseminomatous testicular tumors.
    Bodrogi I; Baki M; Horti J; Liszka G; Ottó S; Hindy I; Sugár J; Eckhardt S
    Neoplasma; 1990; 37(4):445-50. PubMed ID: 1700311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VP-16-213 (etoposide) in the management of germinal testis tumors.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():391-400. PubMed ID: 2421333
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I; Ghilezan N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
    [No Abstract]   [Full Text] [Related]  

  • 8. The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.
    Stoter G
    Prog Clin Biol Res; 1985; 203():437-47. PubMed ID: 2421335
    [No Abstract]   [Full Text] [Related]  

  • 9. Our experience in regard to the relationship between the size of retroperitoneal lymph node metastases and the effect of chemotherapy in non seminomatous germ cell tumors.
    Guazzieri S; Ferro G; Lembo A; Merlo F; Sperandio P; Pagano F
    Prog Clin Biol Res; 1985; 203():457-62. PubMed ID: 2421337
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of the German studies (MAHO) for treatment of testicular germ cell tumors in children--an update].
    Schmidt P; Haas RJ; Göbel U; Calaminus G
    Klin Padiatr; 2002; 214(4):167-72. PubMed ID: 12165897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer of the testis: a new paradigm.
    Einhorn LH
    Hosp Pract (Off Ed); 1986 Apr; 21(4):165-72, 175-8. PubMed ID: 2420812
    [No Abstract]   [Full Text] [Related]  

  • 12. [Raynaud's disease after treatment with bleomycin and vinblastine].
    Dzieza-Lalowicz I; Mykała-Cieśla J
    Pol Tyg Lek; 1986 Feb; 41(7):218-9. PubMed ID: 2423995
    [No Abstract]   [Full Text] [Related]  

  • 13. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
    Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
    J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Total remission of advanced cancer of the testis with the use of the VAB6 schedule: experience with 40 cases].
    Srougi M; Simon SD; de Góes GM
    AMB Rev Assoc Med Bras; 1985; 31(3-4):52-8. PubMed ID: 2417287
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemotherapy of disseminated germ cell tumors of the testis].
    Tiuliandin SA
    Sov Med; 1987; (11):78-81. PubMed ID: 2451298
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cisplatin-induced nephrotoxic side effects of cytostatic chemotherapy of testicular tumors].
    Rebmann U; Oehlmann U; Warnack W
    Z Exp Chir Transplant Kunstliche Organe; 1990; 23(2):83-5. PubMed ID: 1703720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of stage I nonseminomatous testicular cancer with one cycle of adjuvant chemotherapy].
    Corti Ortíz D; Fonerón Burgos A; Troncoso Schifferli L
    Actas Urol Esp; 1997; 21(10):961-3. PubMed ID: 9494159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon and cryoglobulinemia during chemotherapy for testicular carcinoma.
    Dunlop PR; Hendy-Ibbs PM
    Cancer Treat Rep; 1983 Mar; 67(3):317-8. PubMed ID: 6187453
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
    Fizazi K; Do KA; Wang X; Finn L; Logothetis CJ; Amato RJ
    Ann Oncol; 2002 Jan; 13(1):125-34. PubMed ID: 11863094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.